Daridorexant for the Treatment of Insomnia

Keyphrases

• Insomnia Treatment 100%
• Insomnia 100%
• Daridorexant 100%
• Mechanism of Action 16%
• Sleep Disorders 16%
• Orexin 16%
• Receptor Antagonist 16%
• Comorbidity 16%
• Sedative 16%
• Complex Disorders 16%
• First-line Therapy 16%
• Pharmacotherapy 16%
• Benzodiazepines 16%
• US FDA 16%
• Daytime Functioning 16%
• Benzodiazepine Receptor Agonists 16%
• Histamine Receptor Antagonist 16%
• Traditional Treatment 16%
• Sleep Quality 16%
• Insomnia Symptoms 16%
• Cognitive Behavioral Therapy for Insomnia (CBT-I) 16%
• Multifactorial Approach 16%
• Orexin Receptor Antagonist 16%
• Class-based 16%
• OX1 Receptor 16%
• OX2 Receptor 16%
• Melatonin Receptor Agonist 16%

Neuroscience

• Receptor Antagonist 100%
• Orexin 50%
• Dual Orexin Receptor Antagonist 50%
• Receptor Agonists 50%
• Benzodiazepine Receptor 50%
• Cognitive Behavioral Therapy 50%
• Histamine Receptor 50%
• Melatonin Receptor Agonist 50%
• Quality of Sleep 50%
• Comorbidity 50%
• Drug Therapy 50%
• Side Effect 50%
• Sedative 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Pharmacotherapy 50%
• Orexin Receptor Antagonist 50%
• Orexin 50%
• Receptor Antagonist 50%
• Antihistaminic Agent 50%
• Benzodiazepine Receptor Stimulating Agent 50%
• Melatonin Receptor Agonist 50%
• Comorbidity 50%
• Side Effect 50%
• Sedative 50%